RPG Life Sciences Limited (BOM:532983)

Market Cap	36.40B
Revenue (ttm)	6.66B
Net Income (ttm)	2.15B
Shares Out	n/a
EPS (ttm)	130.25
PE Ratio	16.90
Forward PE	n/a
Dividend	24.00 (1.09%)
Ex-Dividend Date	Jun 27, 2025

Volume	2,702
Average Volume	3,944
Open	2,207.05
Previous Close	2,220.45
Day's Range	2,200.00 - 2,239.40
52-Week Range	1,772.05 - 2,715.90
Beta	n/a
RSI	42.59
Earnings Date	Jan 28, 2026

About RPG Life Sciences

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and finished dosage formulations for various therapies, which include nephrology, rheumatology...

• Industry: Pharmaceutical Preparations
• Founded: 1968
• Employees: 1,331
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532983

Financial Performance

In 2024, RPG Life Sciences's revenue was 6.53 billion, an increase of 12.26% compared to the previous year's 5.82 billion. Earnings were 1.83 billion, an increase of 109.03%.